These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 6951095)
21. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II. Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962 [TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226 [TBL] [Abstract][Full Text] [Related]
23. Depression of DNA synthesis in mouse spleen after treatment with 5-aza-2'-deoxycytidine. Cihák A; Veselý J J Natl Cancer Inst; 1979 Oct; 63(4):1035-9. PubMed ID: 90150 [TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity. Smith PG; Thomas HD; Barlow HC; Griffin RJ; Golding BT; Calvert AH; Newell DR; Curtin NJ Clin Cancer Res; 2001 Jul; 7(7):2105-13. PubMed ID: 11448930 [TBL] [Abstract][Full Text] [Related]
25. Biological characterization of a prolonged antileukemic effect of 5-azacytidine. Presant CA; Valeriote F; Vietti TJ Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294 [TBL] [Abstract][Full Text] [Related]
26. Purine modulation of thymidine activity in L1210 leukemia cells in vitro. Leyva A; Appel H; Pinedo HM Leuk Res; 1982; 6(4):483-90. PubMed ID: 7144228 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro. Jackson DV; Bender RA Cancer Res; 1979 Nov; 39(11):4346-9. PubMed ID: 291476 [TBL] [Abstract][Full Text] [Related]
28. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654). Skórski T; Kawalec M Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191 [TBL] [Abstract][Full Text] [Related]
29. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. Keyomarsi K; Moran RG Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577 [TBL] [Abstract][Full Text] [Related]
30. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells. Piper AA; Nott SE; Mackinnon WB; Tattersall MH Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448 [TBL] [Abstract][Full Text] [Related]
31. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide. Skórski T; Kawalec M Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130 [TBL] [Abstract][Full Text] [Related]
32. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding. Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290 [TBL] [Abstract][Full Text] [Related]
33. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
34. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422 [TBL] [Abstract][Full Text] [Related]
35. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium. Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074 [TBL] [Abstract][Full Text] [Related]
36. Ribo- and deoxyribonucleoside effect on 3'-amino-2',3'-dideoxycytidine-induced cytotoxicity in cultured L1210 cells. Mancini WR; Lin TS Biochem Pharmacol; 1983 Aug; 32(16):2427-32. PubMed ID: 6615544 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biologic evaluation of the dopamine analog N-acetyldopamine in experimental leukemia in mice. Wick MM; Mui A J Natl Cancer Inst; 1981 Feb; 66(2):351-4. PubMed ID: 6935484 [TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice. Stern AM; Abeles RH; Tashjian AH Cancer Res; 1984 Dec; 44(12 Pt 1):5614-8. PubMed ID: 6498822 [TBL] [Abstract][Full Text] [Related]
39. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes. Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083 [TBL] [Abstract][Full Text] [Related]
40. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system. Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]